Literature DB >> 26609421

Methicillin resistant Staphylococcus aureus meningitis.

Noella Maria Delia Pereira1, Ira Shah1, Alpana Ohri1, Forum Shah1.   

Abstract

Methicillin resistant Staphylococcus aureus (MRSA) meningitis is rarely known to occur in children. We report an 11-year-old girl with fever, headache and vomiting, right hemiparesis with left-sided upper motor neuron facial nerve palsy and bladder incontinence. On investigation, she was found to have MRSA meningitis with an acute left thalamo-corpuscular infarct. She was treated with vancomycin, linezolid and rifampicin. She recovered successfully with residual right-sided lower limb monoparesis. MRSA meningitis is rare but can occur in children.

Entities:  

Year:  2015        PMID: 26609421      PMCID: PMC4652058          DOI: 10.1093/omcr/omv064

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


INTRODUCTION

Community-acquired (CA) methicillin resistant Staphylococcus aureus (MRSA) has emerged as a pathogen of major importance in pediatric patients. Though hospital-acquired (HA) MRSA is commonly seen in hospitalized individuals with underlying predisposing medical conditions, CA-MRSA may occur without any predisposing factor and usually presents with skin and soft tissue infection [1]. Common organisms causing meningitis in neonates and children are Group B Streptococcus, Escherichia coli, Listeria monocytogenes, Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitis [2]. In one study, incidence of S. aureus meningitis was 6% of which MRSA meningitis was 18% [3]. MRSA meningitis is seen equally in post-operative patients and hematogenous meningitis [4]. We present an 11-year-old girl with CA-MRSA with meningitis who had a favorable outcome.

CASE REPORT

An 11-year-old girl presented with fever for 10 days, headache for 4 days and vomiting for 2 days, altered sensorium and left eye swelling since the morning of presentation to us. On examination, weight was 23 kg and height was 143 cm. She had neck stiffness with right-sided hemiparesis with left-sided upper motor neuron facial nerve palsy and bladder incontinence. Deep tendon reflexes were brisk bilaterally. She was drowsy but arousable. Other systems were normal. Left eye cellulitis was present. She had received intramuscular ceftriaxone in left buttock for the above complaints from another hospital. There was no history of boils or pus-filled vesicles previously. Investigations showed hemoglobin 9.3g%, white blood cells count 13 600 cells/cumm (92% polymorphs, 8% lymphocytes), platelets 3 59 000/cumm, erythrocyte sedimentation rate 93 mm at the end of 1 h, C-reactive protein 61 mg/l and blood culture showed no growth. Serial cerebrospinal fluid (CSF) examinations were done and are depicted in Table I. CSF culture grew MRSA on Day 11 of hospitalization sensitive to vancomycin, linezolid and rifampicin. CSF latex agglutination for S. pneumoniae and H. influenzae was negative. CSF TB-MGIT and Gene X pert were negative. MRI Brain with contrast (Fig. 1) revealed an acute infarct in the left thalamo-capsular region with a discrete focus of acute infarct in the left subcortical frontal white matter, appearing hypointense on ADC maps and hyperintense on FLAIR images. Mild diffuse abnormal leptomeningeal enhancement was also noted suggestive of meningitis.
Table 1.

Cerebrospinal fluid examination

Day 1Day 6Day 11
AppearanceColorless, clearColorless, hazyColorless, slightly hazy
Total cell count/cumm211011803200
Polymorphs (%)903050
Lymphocytes (%)107050
Proteins (mgm%)5506560
Sugar (mgm%)244432
Serum glucose (mgm%)8694-
Gram stainPus cells, occasional red blood cells, occasional Gram negative cocciPus cells, no organism seenPus cells, no organism seen
India inkCryptococcus not seen
Zeil–Neilson stainAcid fast bacilli (AFB) not seenAFB not seenAFB not seen
Figure 1:

MRI Brain with contrast (axial view) showing acute left thalamo-corpuscular infarct.

Cerebrospinal fluid examination MRI Brain with contrast (axial view) showing acute left thalamo-corpuscular infarct. She was initially treated with IV ceftriaxone and IV vancomycin for meningitis but had no response. After CSF grew MRSA, her antibiotics were changed to IV vancomycin (60 mg/kg/day q6 hourly), IV linezolid (10 mg/kg/dose thrice daily) and rifampicin (10 mg/kg/dose twice daily) for 28 days. Echocardiography did not show infective endocarditis. Decolonization measures with chlorhexidine bath and nasal mupirocin were done daily. Nasal swab of patient and her parents showed no growth. The child improved. Right-sided lower limb paresis persisted. Facial nerve palsy resolved, and bladder continence improved. Child is now on regular follow-up.

DISCUSSION

Central nervous system (CNS) infections caused by MRSA occur as a complication of a neurosurgical procedure, in association with a contiguous focus of infection, or hematogenously as a complication of bacteremia or infective endocarditis. Treatment is difficult because of the critical location of these infections and the blood brain barrier, which limits the penetration of systemically administered antibiotics to the site of infection. Thus, surgical drainage of focal abscesses and removal of any foreign body, such as an infected ventriculo-peritoneal shunt, should be performed whenever possible [5]. Children identified to have Panton-Valentine leukocidin (PVL) CA-MRSA infections have higher levels of inflammation markers (C-reactive protein and sedimentation rate), and it has been linked to severe necrotizing pneumonia, furunculosis and severe osteomyelitis. Acquisition of Type I arginine catabolic mobile element (ACME) may allow CA-MRSA to colonize the skin on a permanent basis, thereby enhancing the likelihood of a skin infection occurring upon any disruption of the skin barrier. Phenol-soluble modulin (PSM) peptides are expressed at a higher level in CA-MRSA when compared with HA-MRSA, which prompts suggestion that differences in global virulence regulation could be an important factor in CA-MRSA virulence [6]. Two distinct pathogenic mechanisms for MRSA meningitis include post-operative and spontaneous [7]. Other predisposing factors for CA-MRSA include preseptal cellulitis, otitis media and clivial osteomyelitis [8, 9]. In our patient, left eye cellulitis was a predisposing factor for spontaneous MRSA meningitis. Other complications of CA-MRSA include zygomatic osteomyelitis, cavernous sinus thrombosis and Bell's palsy [8, 10]. In our patient, an acute infarct in the left thalamo-capsular region was seen as a complication with residual right lower limb monoparesis seen as a focal neurological deficit. Vancomycin and rifampicin are the antibiotics of choice for MRSA meningitis with complications as per Infectious Disease Society of America guidelines and are given for 4–6 weeks. Vancomycin has been the drug of choice, but outcomes have been very poor when it has been used as monotherapy. Experts recommend rifampicin in combination with vancomycin for meningitis and other CNS infections. High dose continuous infusion of vancomycin may be considered in patients not responding to standard dosing methods. CSF penetration was increased, and concentrations were almost doubled, compared with standard dosing, when vancomycin was administered as a 15 mg/kg loading dose, followed by continuous infusion of 50–60 mg/kg/day for patients with normal renal function [5]. Similarly in our patient, there was initially no response to vancomycin, and after culture grew MRSA, linezolid and rifampicin were added following which patient responded. CA-MRSA meningitis is rare in children and can occur without predisposing factors. A strong clinical suspicion and timely intervention are required to ensure good outcome.

AUTHORS’ CONTRIBUTIONS

All authors were involved in patient management, preparation of manuscript and approving the final version.

CONFLICT OF INTEREST STATEMENT

None declared.
  8 in total

1.  Methicillin-Resistant Staphylococcus aureus central nervous system infections--Analysis and outcome.

Authors:  Veena H B Kumari; Arun R Babu; Dwarakanath Srinivas; Nagarathna Siddaiah; Sampath Somanna
Journal:  Br J Neurosurg       Date:  2015-02-17       Impact factor: 1.596

2.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

3.  Community acquired methicillin-resistant Staphylococcus aureus preseptal cellulitis complicated by zygomatic osteomylitis, cavernous sinus thrombosis and meningitis in a healthy child.

Authors:  Khaled Menif; Asma Bouziri; Aida Borgi; Ammar Khaldi; Lilia Ben Hassine; Nejla Ben Jaballah
Journal:  Fetal Pediatr Pathol       Date:  2011-03-30       Impact factor: 0.958

Review 4.  Staphylococcus aureus meningitis: case series and literature review.

Authors:  Javier Aguilar; Varinia Urday-Cornejo; Susan Donabedian; Mary Perri; Robert Tibbetts; Marcus Zervos
Journal:  Medicine (Baltimore)       Date:  2010-03       Impact factor: 1.889

5.  MRSA with progression from otitis media and sphenoid sinusitis to clival osteomyelitis, pachymeningitis and abducens nerve palsy in an immunocompetent 10-year-old patient.

Authors:  Matthew B Laurens; Randy M Becker; Jennifer K Johnson; Jeffrey S Wolf; Karen L Kotloff
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2008-05-09       Impact factor: 1.675

Review 6.  Methicillin-resistant Staphylococcus aureus: pediatric perspective.

Authors:  M W Kline; E O Mason
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

7.  Staphylococcus aureus meningitis: a broad-based epidemiologic study.

Authors:  L S Schlesinger; S C Ross; D R Schaberg
Journal:  Medicine (Baltimore)       Date:  1987-03       Impact factor: 1.889

Review 8.  Molecular pathogenesis of Staphylococcus aureus infection.

Authors:  George Y Liu
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.